Dell BIOS vulnerability allows arbitrary code execution with high privilege
CVE-2024-47238

6.7MEDIUM

Key Information:

Vendor

Dell
Status
Dell Client Platform BiOS
Vendor
CVE Published:
12 December 2024

What is CVE-2024-47238?

The Dell Client Platform BIOS is affected by an input validation vulnerability in an externally developed component. This flaw may allow a highly privileged attacker with local access to exploit the vulnerability, potentially leading to arbitrary code execution on the affected system. Addressing this issue is vital for maintaining the integrity and security of the system's BIOS, as improper input handling could facilitate unauthorized actions and compromise sensitive data.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Dell Client Platform BIOS < 1.29.0

Dell Client Platform BIOS < 1.19.0

Dell Client Platform BIOS < 1.25.0

References

https://www.dell.com/support/kbdoc/en-us/000227595/dsa-20...
vendor-advisory

CVSS V3.1

Score:
6.7
Severity:
MEDIUM
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
High
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

Credit

Dell Technologies would like to thank Eclypsium for reporting this issue.
JSON
.